Safety, Pharmacokinetics and Pharmacodynamics of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2013 by Oramed, Ltd.
Sponsor:
Collaborator:
Integrium
Information provided by (Responsible Party):
Oramed, Ltd.
ClinicalTrials.gov Identifier:
NCT01889667
First received: June 19, 2013
Last updated: July 17, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)